Veradermics (MANE), a hair loss therapy developer, files for a U.S. IPO, targeting up to $534M valuation and $182M in net proceeds. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results